AstraZeneca’s supplemental New Drug Application (sNDA) for Tagrisso has been accepted and granted Priority Review in the US for treating adult patients with unresectable, Stage III epidermal growth factor receptor-mutated (EGFRm) non-small cell lung cancer (NSCLC) after chemoradiotherapy (CRT). If…
Genentech, a member of the Roche Group, shared today groundbreaking 5-year findings reaffirming the lasting effectiveness and safety of Evrysdi® (risdiplam) in children diagnosed with Type 1 spinal muscular atrophy (SMA). These insights stem from the open-label extension of the…
Arcturus Therapeutics Holdings Inc. (Nasdaq: ARCT), a global leader in messenger RNA medicines, focused on addressing unmet medical needs in infectious diseases and rare liver and respiratory conditions, unveiled Phase 1 findings in healthy volunteers and interim Phase 1b data…
The “Contact Layer Dressings Market – A Global and Regional Analysis: Focus on Region, Country-Level Analysis, and Competitive Landscape – Analysis and Forecast, 2023-2030” report has been added to ResearchAndMarkets.com’s offering. The global contact layer dressings market, valued at $538.3 million in 2022, is…
Helix, a prominent population genomics company, has introduced new clinico-genomic datasets aimed at empowering life science firms in advancing precision medicine drug discovery and development. These datasets, cultivated through Helix’s extensive collaborations with health systems, encompass comprehensive longitudinal clinical and…
Deborah Borst, a 74-year-old resident of Michigan, never fretted over her health, enjoying a life marked by robust well-being. Her hospital visits were limited to the joyous occasions of childbirth. However, in February 2021, her health narrative took an unexpected…
Incyte has finalized its acquisition of Escient Pharmaceuticals, a company specializing in the development of small molecule therapeutics for immune and neuro-immune disorders. The acquisition enhances Incyte’s Inflammation and Autoimmunity portfolio, reinforcing its dedication to addressing the pressing needs of…
WuXi Biologics, a prominent global Contract Research, Development, and Manufacturing Organization (CRDMO), has released its 2023 Environmental, Social, and Governance (ESG) Report, showcasing significant advancements in sustainable development. Aligned with its vision and mission, WuXi Biologics’ ESG strategy is deeply…
Shionogi & Co., Ltd. recently announced that its subsidiary, Qpex Biopharma, Inc., has exercised a $10 million option granted by the Biomedical Advanced Research and Development Authority (BARDA). This additional funding, part of an ongoing partnership with BARDA, aims to…
Today, Takeda announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has recommended the approval, under exceptional circumstances, of recombinant ADAMTS13 (rADAMTS13) for treating ADAMTS13 deficiency in both children and adult patients suffering from…
Sanofi to Appeal Delaware Court’s Decision on Zantac Sanofi has expressed disappointment with the recent decision by the State of Delaware court and intends to appeal. The company maintains that there is no reliable scientific evidence linking Zantac to cancer,…
Imagine a contact lens that reshapes the cornea while you sleep, improving your vision. Picture wearing a contact lens equipped with technology to alleviate the strain from increased digital screen time. These innovations and more have been made possible by…